Immix Biopharma Inc   (IMMX)
Other Ticker:  


Immix Biopharma Inc

IMMX's Financial Statements and Analysis

Immix Biopharma Inc narrowed III. Quarter net loss per share of $-0.11 compare to net loss per share of $-6.64 recorded in the same quarter a year ago a decrease compare to $-0.11 realized in previous quarter.

III. Quarter
Earnings Per Share Revenues
$ -0.11 $  0 Mill
$+6.53     Unch.    

Immix Biopharma Inc 's Revenue fell by 0 % in III. Quarter (Sep 30 2022) year on year, to $0 million and declined by sequentially.

Immix Biopharma Inc is Expected to report next financial results on March 27, 2023.

More on IMMX's Income Statement

Immix Biopharma Inc 's in III. Quarter recorded net loss of $-1.535 million, an improvement compare to net loss of $-24.384 million in 2021 a year ago.

Sequentially net loss narrowed from net loss of $-1.563 million realized in previous quarter.

More on IMMX's Growth

In III. Quarter company's net cash and cash equivalents decreased by $-1 million

Immix Biopharma Inc does not pay out common stock dividend.

In trailing twelve-month period Immix Biopharma Inc payed $ -0.25 cash per share, on a free-cash flow basis .